This study, through multi-omics integrative analysis, provides the first evidence of a causal link between mitochondrial-related genes (LIAS, TARS2, HEBP1, PNKD) and cholelithiasis, and evaluates their potential as viable drug targets. This evidence concerns the gene TARS2 and cholelithiasis.